Page last updated: 2024-11-07

kemptide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID100074
SCHEMBL ID7741841
MeSH IDM0113728

Synonyms (14)

Synonym
LS-15338
nsc-332190
65189-71-1
nsc332190
kemptide ,
leucyl-arginyl-arginyl-alanyl-seryl-leucyl-glycine
leu-arg-arg-ala-ser-leu-gly
2-[[2-[[2-[2-[[2-[[2-[(2-amino-4-methylpentanoyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoylamino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]acetic acid
nsc 332190
glycine, n-(n-(n-(n-(n2-(n2-l-leucyl-l-arginyl)-l-arginyl)-l-alanyl)-l-seryl)-l-leucyl)-
kemptide acetate salt
SCHEMBL7741841
n-[17-amino-11,14-bis(3-carbamimidamidopropyl)-1,4,7,10,13,16-hexahydroxy-5-(hydroxymethyl)-8,19-dimethyl-2-(2-methylpropyl)-3,6,9,12,15-pentaazaicosa-3,6,9,12,15-pentaen-1-ylidene]glycine
DTXSID80983766

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" For both rat and hamster cell lines, the insulin dose-response curves from cells that expressed the mutant receptors were identical to those from the appropriate controls that over expressed the normal insulin receptors."( The pathway mediating insulin's effects on pyruvate dehydrogenase bypasses the insulin receptor tyrosine kinase.
Gottschalk, WK, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (162)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (17.28)18.7374
1990's80 (49.38)18.2507
2000's33 (20.37)29.6817
2010's19 (11.73)24.3611
2020's2 (1.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.83 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other166 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]